Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

MIT Spin-Off Develops Material Mimicking Human Skin

Skin under the eye on the left is treated with XPL, while skin under the other eye is untreated (Olivio Labs and Mass. Institute of Technology)

9 May 2016. A substance that emulates properties of youthful human skin was shown in pilot tests with human subjects to outperform other materials used for wound . . . → Read More: MIT Spin-Off Develops Material Mimicking Human Skin

566 New Drugs in Pipeline for Orphan Diseases

(angelsalamag054, Pixabay)

9 May 2016. A report by an industry group says 566 drugs designed to treat rare diseases are now in clinical testing by pharmaceutical companies. The report, prepared by Pharmaceutical Research and Manufacturers of America, or PhRMA, and the ALS Association, credits many of these new drugs to incentives in legislation . . . → Read More: 566 New Drugs in Pipeline for Orphan Diseases

Genome-Editing Company Raises $108 Million in IPO

Artist depiction of Cas9 protein editing a gene (Jennifer Doudna, University of California – Berkeley)

6 May 2016. Intellia Therapeutics, a developer of therapies based on genome editing, issued its initial public stock offering, raising $108 million. The Cambridge, Massachusetts enterprise, less than 2 years old, issued 6 million shares priced at $18.00. . . . → Read More: Genome-Editing Company Raises $108 Million in IPO

Genomics, Data Tools Track MRSA Outbreaks in Europe

Microreact.org screen showing European population genomic snapshot of Staphylococcus aureus (Microreact.org)

6 May 2016. A combination of whole-genome sequencing and data visualization tools now makes it possible to track the spread of antibiotic-resistant bacteria in European health facilities. A Europe-wide team led by Wellcome Trust Sanger Institute and Imperial College London described their . . . → Read More: Genomics, Data Tools Track MRSA Outbreaks in Europe

Trial Underway Testing Antibody for Celiac Disease

(TiBine, Pixabay)

5 May 2016. A clinical trial testing an engineered antibody therapy for celiac disease in people that do not respond to a gluten-free diet began treating its first patients. The trial is conducted by Celimmune LLC, a biopharmaceutical company in in Lebanon, New Jersey, but patients are recruited in Finland, where . . . → Read More: Trial Underway Testing Antibody for Celiac Disease

Autonomous Robot Shown Better at Soft-Tissue Surgery

Smart Tissue Autonomous Robot, or Star, surgical system (Children’s National Health System)

5 May 2016. A robotic arm, programmed to work autonomously under direction of a surgeon, was shown superior at soft-tissue surgery with pigs than human surgeons and robot-assisted surgery. Results of these tests, conducted by a team from Children’s National Health . . . → Read More: Autonomous Robot Shown Better at Soft-Tissue Surgery

Genomic Variations Reveal Cholesterol, Heart Disease Risks

(CIRM.gov)

4 May 2016. A review of genome and blood test records from a large group of people in Iceland identified genetic sequencing variations associated with risk factors connecting cholesterol levels to heart disease. Results of the analysis, conducted by deCode Genetics in Reykjavik, Iceland, appear this week in the journal Nature Genetics . . . → Read More: Genomic Variations Reveal Cholesterol, Heart Disease Risks

Engineered Protein Advances to Treat Genetic Blood Disorders

Red blood cells with sickle cell disease (NCATS.NIH.gov)

4 May 2016. Lab tests by a biotechnology company show an engineered protein can block the actions of genes responsible for low normal hemoglobin production in people with inherited blood disorders like sickle cell disease. The findings of researchers from Acetylon Pharmaceuticals Inc. in Boston . . . → Read More: Engineered Protein Advances to Treat Genetic Blood Disorders

Patent Granted for RNA Transcription Technology

Jeannie Lee (RaNA Therapeutics)

3 May 2016. A technology that blocks RNA molecules from activating chemicals in the body suppressing the working of genes to treat or prevent disease received a U.S. patent. The Patent and Trademark Office awarded patent number 9,328,346 to five inventors and assigned the patent to the parent company . . . → Read More: Patent Granted for RNA Transcription Technology

Lung Function App Service Expanded to Any Phone

SpiroCall provides spirometry tests with early cell phones and landlines. (University of Washington)

3 May 2016. A computer science lab extended the abilities of its smartphone app that measures lung function to a call-in service for any phone in the world. The team led by engineering and computer science professor Shwetak Patel at . . . → Read More: Lung Function App Service Expanded to Any Phone